Using the Behaviour Change Wheel and modified Delphi method to identify behavioural change techniques for improving adherence to smoking cessation medications.

Humans Smoking Cessation / methods Delphi Technique Smoking Behavior Therapy Motivation
Adherence Behaviour change wheel Nicotine replacement therapy Pharmacotherapy Smoking cessation

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
17 07 2023
Historique:
received: 20 01 2023
accepted: 10 07 2023
medline: 18 7 2023
pubmed: 17 7 2023
entrez: 16 7 2023
Statut: epublish

Résumé

Medication adherence is a crucial component of the pharmacological treatment of smoking. Previous interventions targeted to improve adherence to smoking cessation medications (SCMs) were designed using pragmatic approaches. This study aims to develop a comprehensive intervention strategy to improve adherence to SCMs using the Behaviour Change Wheel (BCW) and a modified Delphi method. Recommendations for the design of intervention strategies were based on the BCW guide and six studies conducted by the research team. Factors related to healthcare providers and consumers (person making a quit attempt) that showed associations with adherence were mapped into the Capability, Opportunity, Motivation, Behaviour (COM-B) model, and corresponding intervention functions and policy categories. Interventions were then represented using the Behaviour Change Technique Taxonomy. Finally, a modified Delphi study using 17 experts was conducted to evaluate the nominated strategies using the Acceptability, Practicability, Effectiveness, Affordability, Side-effects, and Equity (APEASE) criteria. Following a stepped approach, an adherence support wheel was designed to guide implementation strategies and programmes. Thirteen intervention strategies were selected. The selected interventions include providing detailed instructions on how to use SCMs; establishing realistic expectations from SCMs; and providing training for healthcare providers regarding comprehensive smoking cessation care with specifics on the provision of adherence support. The BCW guide and a modified Delphi were applied successfully to design interventions tailored to improve adherence to SCMs. Improving adherence to SCMs requires a comprehensive intervention approach involving various stakeholders. Future research is needed to assess the effectiveness of the nominated intervention strategies.

Sections du résumé

BACKGROUND
Medication adherence is a crucial component of the pharmacological treatment of smoking. Previous interventions targeted to improve adherence to smoking cessation medications (SCMs) were designed using pragmatic approaches. This study aims to develop a comprehensive intervention strategy to improve adherence to SCMs using the Behaviour Change Wheel (BCW) and a modified Delphi method.
METHODS
Recommendations for the design of intervention strategies were based on the BCW guide and six studies conducted by the research team. Factors related to healthcare providers and consumers (person making a quit attempt) that showed associations with adherence were mapped into the Capability, Opportunity, Motivation, Behaviour (COM-B) model, and corresponding intervention functions and policy categories. Interventions were then represented using the Behaviour Change Technique Taxonomy. Finally, a modified Delphi study using 17 experts was conducted to evaluate the nominated strategies using the Acceptability, Practicability, Effectiveness, Affordability, Side-effects, and Equity (APEASE) criteria.
RESULTS
Following a stepped approach, an adherence support wheel was designed to guide implementation strategies and programmes. Thirteen intervention strategies were selected. The selected interventions include providing detailed instructions on how to use SCMs; establishing realistic expectations from SCMs; and providing training for healthcare providers regarding comprehensive smoking cessation care with specifics on the provision of adherence support.
CONCLUSION
The BCW guide and a modified Delphi were applied successfully to design interventions tailored to improve adherence to SCMs. Improving adherence to SCMs requires a comprehensive intervention approach involving various stakeholders. Future research is needed to assess the effectiveness of the nominated intervention strategies.

Identifiants

DOI: 10.1186/s12889-023-16278-3 PMID: 37455312 PMC: PMC10351182
pubmed: 37455312
doi: 10.1186/s12889-023-16278-3
pii: 10.1186/s12889-023-16278-3
pmc: PMC10351182
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1362

Informations de copyright

© 2023. The Author(s).

Références

Cochrane Database Syst Rev. 2013 May 31;(5):CD009329
pubmed: 23728690
J Subst Abuse Treat. 2016 Aug;67:22-9
pubmed: 27296658
Ophthalmol Glaucoma. 2022 Jan-Feb;5(1):40-46
pubmed: 33892170
Int J Ment Health Syst. 2014 Nov 21;8(1):46
pubmed: 25473416
Cochrane Database Syst Rev. 2014 Nov 20;(11):CD000011
pubmed: 25412402
Drug Alcohol Rev. 2021 Nov;40(7):1294-1307
pubmed: 33825232
Int J Environ Res Public Health. 2021 Dec 19;18(24):
pubmed: 34948983
Cochrane Database Syst Rev. 2012 May 16;(5):CD000214
pubmed: 22592671
Nicotine Tob Res. 2013 Sep;15(9):1537-44
pubmed: 23430709
N Engl J Med. 2014 Jan 2;370(1):60-8
pubmed: 24382066
Can J Public Health. 2020 Oct;111(5):766-774
pubmed: 32441021
Cochrane Database Syst Rev. 2019 Aug 16;8:CD009164
pubmed: 31425618
Prev Med Rep. 2023 Feb 28;32:102168
pubmed: 36922959
Int J Environ Res Public Health. 2020 Nov 30;17(23):
pubmed: 33265956
Patient Prefer Adherence. 2012;6:127-35
pubmed: 22379363
Breathe (Sheff). 2020 Mar;16(1):190338
pubmed: 32194770
Int J Nurs Stud. 2001 Apr;38(2):195-200
pubmed: 11223060
BMJ Open. 2014 Dec 22;4(12):e006414
pubmed: 25534212
Int J Health Sci (Qassim). 2016 Jul;10(3):425-35
pubmed: 27610066
Addiction. 2011 Jun;106(6):1155-63
pubmed: 21226883
Psychopharmacology (Berl). 2018 Jul;235(7):2065-2075
pubmed: 29696311
Implement Sci. 2006 Feb 23;1:4
pubmed: 16722571
HERD. 2020 Jan;13(1):11-23
pubmed: 31887097
J Behav Med. 2005 Apr;28(2):139-47
pubmed: 15957569
Int J Behav Med. 2015 Dec;22(6):699-708
pubmed: 25805550
Nicotine Tob Res. 2005 Aug;7(4):565-79
pubmed: 16085528
Health Promot J Austr. 2022 Oct 25;:
pubmed: 36284364
BMC Med Res Methodol. 2020 Jun 15;20(1):156
pubmed: 32539717
Milbank Q. 2007;85(1):93-138
pubmed: 17319808
Implement Sci. 2006 Feb 23;1:5
pubmed: 16722583
Implement Sci. 2017 Sep 15;12(1):114
pubmed: 28915815
BMJ. 2007 Nov 17;335(7628):1030
pubmed: 17991935
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
Arch Public Health. 2021 Mar 4;79(1):26
pubmed: 33663575
J Clin Nurs. 2022 Mar;31(5-6):744-754
pubmed: 34231274
Int J Environ Res Public Health. 2021 Nov 21;18(22):
pubmed: 34831981
Implement Sci. 2012 Apr 24;7:38
pubmed: 22531013
PLoS One. 2011;6(6):e20476
pubmed: 21694759
Addiction. 2002 May;97(5):505-16
pubmed: 12033652
Trials. 2019 Sep 2;20(1):547
pubmed: 31477166
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
Psychol Addict Behav. 2017 Mar;31(2):148-153
pubmed: 27736144
BMC Public Health. 2019 Dec 26;19(1):1734
pubmed: 31878901
Addict Behav. 2007 Apr;32(4):875-80
pubmed: 16839698
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Psychopharmacology (Berl). 2005 Feb;177(4):400-8
pubmed: 15289997
Thorax. 2003 May;58(5):435-43
pubmed: 12728167
J Educ Health Promot. 2021 Sep 30;10:353
pubmed: 34761039
J Adv Nurs. 2020 May;76(5):1172-1181
pubmed: 32026506
World J Methodol. 2021 Jul 20;11(4):116-129
pubmed: 34322364
Nicotine Tob Res. 2018 Sep 4;20(10):1163-1172
pubmed: 29059394
Lancet. 2021 Jun 19;397(10292):2337-2360
pubmed: 34051883

Auteurs

Amanual Getnet Mersha (AG)

School of Medicine and Public Health, The University of Newcastle, University Drive, Callaghan, Newcastle, NSW, 2308, Australia. AmanualGetnet.Mersha@uon.edu.au.
Hunter Medical Research Institute, Lot 1, Kookaburra Circuit, New Lambton Heights, Newcastle, NSW, 2305, Australia. AmanualGetnet.Mersha@uon.edu.au.
ORCID: 0000-0002-1183-8517

Michelle Kennedy (M)

School of Medicine and Public Health, The University of Newcastle, University Drive, Callaghan, Newcastle, NSW, 2308, Australia.
Hunter Medical Research Institute, Lot 1, Kookaburra Circuit, New Lambton Heights, Newcastle, NSW, 2305, Australia.

Parivash Eftekhari (P)

School of Medicine and Public Health, The University of Newcastle, University Drive, Callaghan, Newcastle, NSW, 2308, Australia.
Hunter Medical Research Institute, Lot 1, Kookaburra Circuit, New Lambton Heights, Newcastle, NSW, 2305, Australia.

K S Kylie Lee (KSK)

NHMRC Centre of Research Excellence in Indigenous Health and Alcohol, Discipline of Addiction Medicine, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia.
The Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, Sydney, Australia.
National Drug Research Institute, Faculty of Health Sciences, Curtin University, Perth, Australia.
Burnet Institute, Melbourne, Australia.
Centre for Alcohol Policy Research, La Trobe University, Bundoora, VIC, Australia.

Penney Upton (P)

University of Canberra, Health Research Institute, 11 Kirianri Street, Bruce, Canberra, ACT, 2601, Australia.

Catherine Segan (C)

Cancer Council Victoria, Victoria, Australia.
Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Victoria, Australia.

Melissa A Jackson (MA)

School of Medicine and Public Health, The University of Newcastle, University Drive, Callaghan, Newcastle, NSW, 2308, Australia.
Hunter New England Local Health District Drug & Alcohol Clinical Services, 670 Hunter Street, Newcastle, NSW, 2300, Australia.
Drug & Alcohol Clinical Research Improvement Network, 1 Reserve Road, St Leonards, NSW, 2065, Australia.

Kirsty Jennings (K)

School of Medicine and Public Health, The University of Newcastle, University Drive, Callaghan, Newcastle, NSW, 2308, Australia.

Gillian Sandra Gould (GS)

Faculty of Health, Southern Cross University, Hogbin Drive, Coffs Harbour, 2450, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Using the Behaviour Change Wheel and modified...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Comportement › Comportement en matière de santé › Arrêter de fumer › Using the Behaviour Change Wheel and modified...
questionsmedicales.fr › Sciences de l'information › Analyse des systèmes › Méthode Delphi › Using the Behaviour Change Wheel and modified...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Comportement › Fumer › Using the Behaviour Change Wheel and modified...
questionsmedicales.fr › Disciplines et activités comportementales › Psychothérapie › Thérapie comportementale › Using the Behaviour Change Wheel and modified...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Personnalité › Intelligence › Intelligence émotionnelle › Motivation › Using the Behaviour Change Wheel and modified...